Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.
The ethical dimensions of pharmacological cognitive enhancement have been widely discussed in academic circles and the popular media, but missing from the conversation have been the perspectives of physicians - key decision makers in the adoption of new technologies into medical practice. We queried...
Main Authors: | Opeyemi C Banjo, Roland Nadler, Peter B Reiner |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-12-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3001858?pdf=render |
Similar Items
-
ALDO-DHF & PARAMOUNT
by: Ahmed M ElGuindy
Published: (2012-12-01) -
Clinical findings remain paramount
by: Gláucia Maria Moraes Oliveira
Published: (2019-06-01) -
Adaptation, the Paramount Communication Strategy
by: Bastin Georges L.
Published: (2014-02-01) -
Attitudes towards pharmacological cognitive enhancement – a review
by: Kimberly Johanna Schelle, et al.
Published: (2014-04-01) -
A fluke occurrence of paramount significance
by: D Gude, et al.
Published: (2011-01-01)